FGFR3を標的とした新規膀胱癌治療戦略およびHsp90阻害剤による治療耐性克服

• Project/Area Number: 26870174
• Research Category: Grant-in-Aid for Young Scientists (B)
• Allocation Type: Multi-year Fund
• Research Field: Urology; Tumor therapeutics
• Research Institution: Tokyo Medical and Dental University
• Principal Investigator: 竹下 英毅 東京医科歯科大学, 医学部附属病院, その他 (70647081)
• Project Period (FY): 2014-04-01 – 2017-03-31
• Project Status: Adopted (Fiscal Year 2014)
• Budget Amount: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000); Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000); Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000); Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)